Cargando…

Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation

Extracorporeal membrane oxygenation (ECMO), a relevant technology for patients with acute respiratory distress syndrome (ARDS) or acute cardiac failure (ACF), is a frequent cause of systemic inflammatory response syndrome. During sepsis, HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Sébastien, De Tymowski, Christian, Zappella, Nathalie, Snauwaert, Aurélie, Robert, Tiphaine, Lortat-Jacob, Brice, Castier, Yves, Tran-Dinh, Alexy, Tashk, Parvine, Bouzid, Donia, Para, Marylou, Pellenc, Quentin, Atchade, Enora, Meilhac, Olivier, Montravers, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390666/
https://www.ncbi.nlm.nih.gov/pubmed/34446802
http://dx.doi.org/10.1038/s41598-021-96728-3
_version_ 1783743125093613568
author Tanaka, Sébastien
De Tymowski, Christian
Zappella, Nathalie
Snauwaert, Aurélie
Robert, Tiphaine
Lortat-Jacob, Brice
Castier, Yves
Tran-Dinh, Alexy
Tashk, Parvine
Bouzid, Donia
Para, Marylou
Pellenc, Quentin
Atchade, Enora
Meilhac, Olivier
Montravers, Philippe
author_facet Tanaka, Sébastien
De Tymowski, Christian
Zappella, Nathalie
Snauwaert, Aurélie
Robert, Tiphaine
Lortat-Jacob, Brice
Castier, Yves
Tran-Dinh, Alexy
Tashk, Parvine
Bouzid, Donia
Para, Marylou
Pellenc, Quentin
Atchade, Enora
Meilhac, Olivier
Montravers, Philippe
author_sort Tanaka, Sébastien
collection PubMed
description Extracorporeal membrane oxygenation (ECMO), a relevant technology for patients with acute respiratory distress syndrome (ARDS) or acute cardiac failure (ACF), is a frequent cause of systemic inflammatory response syndrome. During sepsis, HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrations decrease, and an association between low lipoprotein levels and poor outcomes was reported. There are no data from patients undergoing ECMO. The goal of this study was to characterize the lipoprotein profiles of ICU patients requiring ECMO. All consecutive patients admitted for ARDS or ACF requiring ECMO were prospectively included. Daily lipoprotein levels and short-term prognosis outcome were assessed. 25 patients were included. On admission, lipoprotein concentrations were low, under the reference values ([HDL-C] = 0.6[0.4–0.8]mmol/L;[LDL-C] = 1.3[1.0–1.7]mmol/L). A statistically significant rise in lipoproteins overtime was observed during the ICU stay. We found no relationship between lipoproteins concentrations and mortality on Day-28 (p = 0.689 and p = 0.979, respectively). Comparison of surviving patients with non-surviving patients did not reveal any differences in lipoproteins concentrations. Stratification between septic and non-septic patients demonstrated that septic patients had lower lipoproteins concentrations on admission (HDL-C: 0.5[0.3–0.6]mmol/l vs 0.8[0.6–0.9]mmol/l, p = 0.003; LDL-C: 1.1[0.9–1.5]mmol/l vs 1.5[1.3–2.6]mmol/l; p = 0.012), whereas these two groups were comparable in terms of severity and outcomes. HDL-C concentrations during ICU hospitalization were also significantly lower in the septic group than in the non-septic group (p = 0.035). In conclusion, Lipoprotein concentrations are low in patients requiring ECMO but are not associated with poor outcomes. The subpopulation of septic patients had lower lipoprotein levels overtime, which reinforces the potential key-role of these particles during sepsis.
format Online
Article
Text
id pubmed-8390666
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83906662021-09-01 Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation Tanaka, Sébastien De Tymowski, Christian Zappella, Nathalie Snauwaert, Aurélie Robert, Tiphaine Lortat-Jacob, Brice Castier, Yves Tran-Dinh, Alexy Tashk, Parvine Bouzid, Donia Para, Marylou Pellenc, Quentin Atchade, Enora Meilhac, Olivier Montravers, Philippe Sci Rep Article Extracorporeal membrane oxygenation (ECMO), a relevant technology for patients with acute respiratory distress syndrome (ARDS) or acute cardiac failure (ACF), is a frequent cause of systemic inflammatory response syndrome. During sepsis, HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) concentrations decrease, and an association between low lipoprotein levels and poor outcomes was reported. There are no data from patients undergoing ECMO. The goal of this study was to characterize the lipoprotein profiles of ICU patients requiring ECMO. All consecutive patients admitted for ARDS or ACF requiring ECMO were prospectively included. Daily lipoprotein levels and short-term prognosis outcome were assessed. 25 patients were included. On admission, lipoprotein concentrations were low, under the reference values ([HDL-C] = 0.6[0.4–0.8]mmol/L;[LDL-C] = 1.3[1.0–1.7]mmol/L). A statistically significant rise in lipoproteins overtime was observed during the ICU stay. We found no relationship between lipoproteins concentrations and mortality on Day-28 (p = 0.689 and p = 0.979, respectively). Comparison of surviving patients with non-surviving patients did not reveal any differences in lipoproteins concentrations. Stratification between septic and non-septic patients demonstrated that septic patients had lower lipoproteins concentrations on admission (HDL-C: 0.5[0.3–0.6]mmol/l vs 0.8[0.6–0.9]mmol/l, p = 0.003; LDL-C: 1.1[0.9–1.5]mmol/l vs 1.5[1.3–2.6]mmol/l; p = 0.012), whereas these two groups were comparable in terms of severity and outcomes. HDL-C concentrations during ICU hospitalization were also significantly lower in the septic group than in the non-septic group (p = 0.035). In conclusion, Lipoprotein concentrations are low in patients requiring ECMO but are not associated with poor outcomes. The subpopulation of septic patients had lower lipoprotein levels overtime, which reinforces the potential key-role of these particles during sepsis. Nature Publishing Group UK 2021-08-26 /pmc/articles/PMC8390666/ /pubmed/34446802 http://dx.doi.org/10.1038/s41598-021-96728-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tanaka, Sébastien
De Tymowski, Christian
Zappella, Nathalie
Snauwaert, Aurélie
Robert, Tiphaine
Lortat-Jacob, Brice
Castier, Yves
Tran-Dinh, Alexy
Tashk, Parvine
Bouzid, Donia
Para, Marylou
Pellenc, Quentin
Atchade, Enora
Meilhac, Olivier
Montravers, Philippe
Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
title Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
title_full Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
title_fullStr Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
title_full_unstemmed Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
title_short Lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
title_sort lipoprotein concentration in patients requiring extracorporeal membrane oxygenation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390666/
https://www.ncbi.nlm.nih.gov/pubmed/34446802
http://dx.doi.org/10.1038/s41598-021-96728-3
work_keys_str_mv AT tanakasebastien lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT detymowskichristian lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT zappellanathalie lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT snauwaertaurelie lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT roberttiphaine lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT lortatjacobbrice lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT castieryves lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT trandinhalexy lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT tashkparvine lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT bouziddonia lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT paramarylou lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT pellencquentin lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT atchadeenora lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT meilhacolivier lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation
AT montraversphilippe lipoproteinconcentrationinpatientsrequiringextracorporealmembraneoxygenation